Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial
Year: 2017
Type: article
Source: Clinical Genitourinary Cancer
Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute, Guy's Hospital, Université Paris-Sud, Institut Gustave Roussy, Azienda Ospedaliera San Camillo-Forlanini, Carlo Forlanini Hospital, Institute of Cancer Research, Royal Marsden Hospital, Cliniques Universitaires Saint-Luc, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, University of Colorado Anschutz, University of Southern California, Keck Hospital of USC, USC Norris Comprehensive Cancer Center, Astellas Pharma (Netherlands), Medivation, Inc. (United States), University of Washington, Fred Hutch Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2592991635